» Articles » PMID: 15690441

Uterine Sarcomas Versus Leiomyomas: Gray-scale and Doppler Sonographic Findings

Overview
Specialty Radiology
Date 2005 Feb 4
PMID 15690441
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of the study was to evaluate the contribution of gray-scale sonography and Doppler flow studies in differentiating between uterine sarcomas of different histologic types and leiomyomas.

Patients And Methods: The study included 111 patients, divided retrospectively into 2 groups: 98 patients with leiomyomas and 13 with postoperative diagnosis of uterine sarcoma. This latter group was further divided into a group of 6 patients with uterine leiomyosarcoma and 7 with malignant mixed mesodermal tumor. The gray-scale sonograms and Doppler parameters in the 3 groups were compared.

Results: The patients with leiomyomas were younger than those with sarcomas (52 years +/- 11 versus 65 years +/- 15, p < 0.05). No differences were noted between the 3 groups regarding gravidity, parity, symptoms upon admission, or findings during physical examination. The sonographic appearances of the leiomyomas were similar to those of the leiomyosarcomas, but in 6/7 cases, they were different from those of the malignant mixed mesodermal tumors. There was a significant difference between the mean resistance index in arterioles of the leiomyomas (0.59 +/- 0.01) and that of the malignant mixed mesodermal tumors (0.41 +/- 0.06) (P < 0.001) but not between those of the leiomyomas and the leiomyosarcomas (0.49 +/- 0.18).

Conclusions: Doppler flow studies may assist in differentiating between leiomyomas and malignant mixed mesodermal tumors but not between leiomyomas and leiomyosarcomas.

Citing Articles

How Frequently Benign Uterine Myomas Appear Suspicious for Sarcoma as Assessed by Transvaginal Ultrasound?.

Cabezas N, Lopez-Picazo A, Diaz P, Valero B, Rodriguez M, Redondo A Diagnostics (Basel). 2023; 13(3).

PMID: 36766608 PMC: 9914371. DOI: 10.3390/diagnostics13030501.


MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement.

Hindman N, Kang S, Fournier L, Lakhman Y, Nougaret S, Reinhold C Radiology. 2022; 306(2):e211658.

PMID: 36194109 PMC: 9885356. DOI: 10.1148/radiol.211658.


Advances in the Preoperative Identification of Uterine Sarcoma.

Liu J, Wang Z Cancers (Basel). 2022; 14(14).

PMID: 35884577 PMC: 9318633. DOI: 10.3390/cancers14143517.


Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Zak K, Zaremba B, Rajtak A, Kotarski J, Amant F, Bobinski M Cancers (Basel). 2022; 14(8).

PMID: 35454875 PMC: 9029111. DOI: 10.3390/cancers14081966.


Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.

Surace A, Bau M, Privitera S, Botta G, Danese S, Plazzotta C Int J Gynaecol Obstet. 2021; 156(2):236-239.

PMID: 33834486 PMC: 9291939. DOI: 10.1002/ijgo.13701.